{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:02:03Z","timestamp":1791118923746,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.neuint.2011.03.013","type":"journal-article","created":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T08:38:36Z","timestamp":1300351116000},"page":"839-849","source":"Crossref","is-referenced-by-count":29,"title":["Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats"],"prefix":"10.1016","volume":"58","author":[{"given":"El\u017cbieta","family":"Lorenc-Koci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Lenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucyna","family":"Antkiewicz-Michaluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga","family":"Wardas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Domin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"\u015amia\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Konieczny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2011.03.013_bib0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tins.2006.12.003","article-title":"Space, time and dopamine","volume":"30","author":"Arbuthnott","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2011.03.013_bib0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ana.20939","article-title":"The proteasomal inhibition model of Parkinson's disease: \u201cboon or bust\u201d?","volume":"60","author":"Beal","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.biophys.28.1.295","article-title":"The proteasome","volume":"28","author":"Bochtler","year":"1999","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.neuint.2011.03.013_bib0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.20937","article-title":"Proteasome inhibition and Parkinson's disease modeling","volume":"60","author":"Bov\u00e9","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0025","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s004010051150","article-title":"Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system","volume":"99","author":"Braak","year":"2000","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2011.03.013_bib0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0304-3940(90)90614-F","article-title":"Evidence for retrograde axonal transport of MPP+ in the rat","volume":"118","author":"Campbell","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2011.03.013_bib0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1523\/JNEUROSCI.3602-07.2008","article-title":"Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice","volume":"28","author":"Chen","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2011.03.013_bib0045","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1093\/emboj\/17.24.7151","article-title":"The ubiquitin-proteasome pathway: on protein death and cell life","volume":"17","author":"Ciechanover","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.neuint.2011.03.013_bib0050","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1042\/bst0310474","article-title":"The ubiquitin proteolytic system and pathogenesis of human diseases: a novel platform for mechanism-based drug targeting","volume":"31","author":"Ciechanover","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuint.2011.03.013_bib0055","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1096\/fj.05-5495com","article-title":"Proteasome inhibition induces reversible impairments in proteins synthesis","volume":"20","author":"Ding","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neuint.2011.03.013_bib0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tins.2006.11.003","article-title":"Interplay between protein synthesis and degradation in the CNS: physiological and pathological implications","volume":"30","author":"Ding","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2011.03.013_bib0065","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1471-4159.2005.03606.x","article-title":"Substrate-mediated enhancement of phosphorylated tyrosine hydroxylase in nigrostriatal dopamine neurons: evidence for a role of alpha-synuclein","volume":"96","author":"Drolet","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2011.03.013_bib0070","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1523\/JNEUROSCI.23-26-08955.2003","article-title":"Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition","volume":"23","author":"Fornai","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2011.03.013_bib0075","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ana.10207","article-title":"Brain proteasomal function in sporadic Parkinson's disease and related disorders","volume":"51","author":"Furukawa","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00401-006-0096-2","article-title":"Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra","volume":"112","author":"Galvin","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0085","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/hmg\/ddi308","article-title":"Molecular pathogenesis of Parkinson's disease","volume":"14","author":"Gandhi","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2011.03.013_bib0090","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuint.2011.03.013_bib0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","article-title":"The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction","volume":"82","author":"Glickman","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuint.2011.03.013_bib0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2818.1999.00457.x","article-title":"The efficiency of systematic sampling in stereology \u2013 reconsidered","volume":"193","author":"Gundersen","year":"1999","journal-title":"J. Microsc."},{"key":"10.1016\/j.neuint.2011.03.013_bib0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03159935","article-title":"Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway","volume":"14","author":"Jellinger","year":"1991","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0110","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ana.20935","article-title":"Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys","volume":"60","author":"Kordower","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0115","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2011.03.013_bib0120","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s11064-009-9986-8","article-title":"Modulation of alpha-synuclein aggregation by dopamine: a review","volume":"34","author":"Leong","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2011.03.013_bib0125","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson's disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2011.03.013_bib0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1568-1637(03)00031-X","article-title":"Monitoring the ubiquitin\/proteasome system in conformational diseases","volume":"2","author":"Lindsten","year":"2003","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuint.2011.03.013_bib0135","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s11064-008-9599-7","article-title":"Silencing alpha-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells","volume":"33","author":"Liu","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2011.03.013_bib0140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.20938","article-title":"Lack of nigrostriatal pathology in a rat model of proteasome inhibition","volume":"60","author":"Manning-Bo\u011f","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2007.06.076","article-title":"Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration","volume":"1168","author":"Mathur","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2011.03.013_bib0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson's disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2011.03.013_bib0155","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/00001756-200208070-00018","article-title":"Proteasome inhibition causes nigral degeneration with inclusion bodies in rats","volume":"13","author":"McNaught","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuint.2011.03.013_bib0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1471-4159.2002.00821.x","article-title":"Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures","volume":"81","author":"McNaught","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2011.03.013_bib0165","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1046\/j.1460-9568.2002.02301.x","article-title":"Aggresome-related biogenesis of Lewy bodies","volume":"16","author":"McNaught","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2011.03.013_bib0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","article-title":"Altered proteasomal function in sporadic Parkinson's disease","volume":"179","author":"McNaught","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0175","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","article-title":"Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease","volume":"56","author":"McNaught","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0180","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.neurobiolaging.2005.08.012","article-title":"Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease","volume":"27","author":"McNaught","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2011.03.013_bib0185","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.20936","article-title":"Proteasome inhibitor-induced model of Parkinson's disease","volume":"60","author":"McNaught","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0190","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/syn.20719","article-title":"The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease","volume":"64","author":"McNaught","year":"2010","journal-title":"Synapse"},{"key":"10.1016\/j.neuint.2011.03.013_bib0195","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1523\/JNEUROSCI.16-20-06331.1996","article-title":"Immunohistochemical distribution and electron microscopic subcellular localization of the proteasome in the rat CNS","volume":"16","author":"Mengual","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2011.03.013_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01253106","article-title":"Autoradiographic localization of dopamine uptake sites in the rat brain with 3H-GBR 12935","volume":"87","author":"Mennicken","year":"1992","journal-title":"J. Neural. Transm. Gen. Sect."},{"key":"10.1016\/j.neuint.2011.03.013_bib0205","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2005.01.024","article-title":"Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition","volume":"380","author":"Miwa","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2011.03.013_bib0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson's disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2011.03.013_bib0215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000202972","article-title":"Nigral degeneration with inclusion body formation and behavioral changes in rats after proteasomal inhibition","volume":"87","author":"Niu","year":"2009","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/j.neuint.2011.03.013_bib0220","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuint.2011.03.013_bib0225","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1242\/jcs.02481","article-title":"Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells","volume":"118","author":"Peng","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuint.2011.03.013_bib0230","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1471-4159.2004.02423.x","article-title":"Could a loss of alpha-synuclein function put dopaminergic neurons at risk?","volume":"89","author":"Perez","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2011.03.013_bib0235","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","article-title":"A role for alpha-synuclein in the regulation of dopamine biosynthesis","volume":"22","author":"Perez","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2011.03.013_bib0240","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1016\/S0021-9258(17)37345-3","article-title":"Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm","volume":"269","author":"Peters","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2011.03.013_bib0245","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00005072-199305000-00001","article-title":"Pathology and biology of the Lewy body","volume":"52","author":"Pollanen","year":"1993","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0250","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1471-4159.2001.00474.x","article-title":"Proteasomal inhibition leads to formation of ubiquitin\/alpha-synuclein-immunoreactive inclusions in PC12 cells","volume":"78","author":"Rideout","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2011.03.013_bib0255","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1471-4159.2005.03124.x","article-title":"Dopaminergic neurons in rat ventral midbrain cultures undergo selective apoptosis and form inclusions, but do not up-regulate iHSP70, following proteasomal inhibition","volume":"93","author":"Rideout","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2011.03.013_bib0260","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0952-7915(98)80040-X","article-title":"Intracellular distribution of proteasomes","volume":"10","author":"Rivett","year":"1998","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0265","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2007.01.033","article-title":"Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders","volume":"257","author":"Sas","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuint.2011.03.013_bib0270","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.20934","article-title":"Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons","volume":"60","author":"Schapira","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0275","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0896-6273(01)00177-5","article-title":"Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases","volume":"29","author":"Sherman","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2011.03.013_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.febslet.2004.03.063","article-title":"alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease","volume":"565","author":"Sidhu","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuint.2011.03.013_bib0285","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"\u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuint.2011.03.013_bib0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2818.1984.tb02501.x","article-title":"The unbiased estimation of number and sizes of arbitrary particles using the disector","volume":"134","author":"Sterio","year":"1984","journal-title":"J. Microsc."},{"key":"10.1016\/j.neuint.2011.03.013_bib0295","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/138920308785915218","article-title":"Alpha-synuclein misfolding and neurodegenerative diseases","volume":"9","author":"Uversky","year":"2008","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.neuint.2011.03.013_bib0300","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1357-2725(02)00380-1","article-title":"Intracellular localization of proteasomes","volume":"35","author":"W\u00f3jcik","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0305","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/pr.59.1.4","article-title":"Emerging roles for ubiquitin and protein degradation in neuronal function","volume":"59","author":"Yi","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuint.2011.03.013_bib0310","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/MN:31:1-3:243","article-title":"Alpha-synuclein and dopamine metabolism","volume":"31","author":"Yu","year":"2005","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2011.03.013_bib0315","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.20932","article-title":"Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats","volume":"60","author":"Zeng","year":"2006","journal-title":"Ann. Neurol."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018611001069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018611001069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T12:06:23Z","timestamp":1637409983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018611001069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0197018611001069"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2011.03.013","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}